45
Participants
Start Date
June 12, 2020
Primary Completion Date
April 28, 2023
Study Completion Date
April 28, 2023
BI 764524
BI 764524
Sham control of BI 764524
Sham control of BI 764524
New York Eye and Ear Infirmary of Mount Sinai, New York
Long Island Vitreoretinal Consultants, Great Neck
Florida Retina Institute, Orlando
Trinity Research, Dothan
Cleveland Clinic, Cleveland
Raj K. Maturi, MD PC, Carmel
Retina Consultants of Texas, The Woodlands
Retina Consultants of Texas, Bellaire
Valley Retina Institute, PA, McAllen
Austin Research Center for Retina, PLLC, Austin
Retina-Vitreous Associates Medical Group, Beverly Hills
Stanford University Medical Center, Palo Alto
Joslin Diabetes Center, Boston
Bradford Royal Infirmary, Bradford
Bristol Eye Hospital, Bristol
Southend University Hospital, Essex
Gloucestershire Royal Hospital, Gloucester
Moorfields Eye Hospital, London
Sunderland Eye Infirmary, Sunderland
Lead Sponsor
Boehringer Ingelheim
INDUSTRY